Abstract:Background and Objective: Non-small cell lung cancer (NSCLC) accounts for 80-85% of all patients with lung cancer and 5-year relative overall survival (OS) rate is less than 20%, so that identifying novel diagnostic and prognostic biomarkers is urgently demanded. The present study attempted to identify potential key genes associated with the pathogenesis and prognosis of NSCLC. Methods: Four GEO datasets (GSE18842, GSE19804, GSE43458, and GSE62113) were obtained from the Gene Expression Omnibus (GEO) database. The differentially expressed genes (DEGs) between NSCLC samples and normal ones were analyzed using limma package, and RobustRankAggreg (RRA) package was used to conduct gene integration. Moreover, Search Tool for the Retrieval of Interacting Genes database (STRING), Cytoscape, and Molecular Complex Detection (MCODE) were utilized to establish protein-protein interaction (PPI) network of these DEGs. Furthermore, functional enrichment and pathway enrichment analyses for DEGs were performed by Funrich and OmicShare. While the expressions and prognostic values of top genes were carried out through Gene Expression Profiling Interactive Analysis (GEPIA) and Kaplan Meier-plotter (KM) online dataset. Results: A total of 249 DEGs (113 upregulated and 136 downregulated) were identified after gene integration. Moreover, the PPI network was established with 166 nodes and 1784 protein pairs. Topoisomerase II alpha (TOP2A), a top gene and hub node with higher node degrees in module 1, was significantly enriched in mitotic cell cycle pathway. In addition, Interleukin-6 (IL-6) was enriched in amb2 integrin signaling pathway. The mitotic cell cycle was the most significant pathway in module 1 with the highest P-value. Besides, five hub genes with high degree of connectivity were selected, including TOP2A, CCNB1, CCNA2, UBE2C, and KIF20A, and they were all correlated with worse OS in NSCLC. Conclusion: The results showed that TOP2A, CCNB1, CCNA2, UBE2C, KIF20A, and IL-6 may be potential key genes, while the mitotic cell cycle pathway may be a potential pathway contribute to progression in NSCLC. Further, it could be used as a new biomarker for diagnosis and to direct the synthesis medicine of NSCLC.

Differential Expression of Genes Involved in Metabolism Between Tumorigenitic Human Leukemia Cell Lines K562 and K562-n

Tumor Associated Gene Expression of Human Leukemia Cell Line with High Tumorigenicity in Nude Mice

[Differential Gene Expression Analysis of Human Leukemic Cell Line with Different Tumorigenic Potentials in Nude Mice].

Study on Expression of Gene Associated with Metabolism in K562-n Cell Line with High Tumorigenicity in Nude Mice

Study on the Change of Gene Expression Profile of High Tumorigenic Cell Line K562-n

Rna-Sequence Analysis Reveals Differentially Expressed Genes (degs) in Patients Exhibiting Different Risks of Tumor Metastasis

ANTITUMOR EFFECTS OF HUMAN IL-15 GENE MODIFIED LUNG CANCER CELL LINE

Genes Encoding Pir51, Beclin 1, RbAp48 and Aldolase B Are Up or Down-Regulated in Human Primary Hepatocellular Carcinoma.

RNA-sequencing and Microarray Data Mining Revealing: the Aberrantly Expressed Mrnas Were Related with a Poor Outcome in the Triple Negative Breast Cancer Patients

[Study on Tumorigenic Mechanism of Human Leukemia Cell Line in Nude Mice].

Spectrum of Gene Expression of a Multi-Drug Resistant Leukemia Cell Line with High Tumorigenicity in Nude Mice

Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis

Comparison of gene expression between metastatic derivatives and their poorly metastatic parental cells implicates crucial tumor–environment interaction in metastasis of head and neck squamous cell carcinoma

cDNA microarray in the research of lymphomagenesis of NHL

Study of the Apoptosis and Metabolism Genes Related to ColorectalCancer with Different Metastatic Potentiality

Gene Expression Profile of Human Hepatocellular Carcinoma Cell Lines with Different Metastatic Potentials

Analysis of differentially expressed genes between the high-metastatic and low-metastatic lung cancer cell lines

Integrative Analysis Reveals Comprehensive Altered Metabolic Genes Linking with Tumor Epigenetics Modification in Pan-Cancer

Screening and identification of distant metastasis-related differentially expressed genes in human squamous cell lung carcinoma.

An RNA-seq-based Gene Expression Profiling of Radiation-Induced Tumorigenic Mammary Epithelial Cells.

The differential activation of metabolic pathways in leukemic cells depending on their genotype and micro-environmental stress